(Date:9/4/2008)... PACIFIC PALISADES, Calif., Sept. 4 /PRNewswi...r and recognized authority in the field of weight,... "Who,s Who in,California," "Who,s Who in The West...," "Who,s Who in Medicine and Health Care" and oth...evote his expertise to exposing the,inaccurate, mi...
(Date:9/4/2008)... BOSTON, CHICAGO, LONDON, NEW YORK, NORWICH, ...- Schofield Publishing, a division of Schofield Me...it has acquired Health and,Safety Monitor publicat... Monitor was launched at the same time as the icon...ked the developing,legislation since then. It has ...
(Date:9/4/2008)... - New Educational Program Kicks Off September,... Month -, LOS ANGELES, Sept. 4 /PRNewswire...NOCC) launched its newest educational initiative, ...Boulevard 3 to honor survivors,friends and family...ucate,women nationwide about the symptoms and risk...
(Date:9/4/2008)... ADDISON, Texas, Sept. 4 /PRNewswire-FirstCal...it is scheduled to present at the Thomas Weisel,Pa...Time on Thursday,September 4, 2008., About ULURU...aceutical company focused on,the development of a ...,oral care products to provide patients and consum...
Breaking Medicine News(10 mins):Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2Health News:Schofield Publishing Enters the Newsletter Market 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 3...wer drinks a week, but also suffer from diseases t...ms with the medications// which they take while dr...s, when compared with men who drink less or more b...Older men who drank moderately or heavily and had ...
...carcity of life saving drugs as most companies hav...dded Tax (VAT) system// implemented since April 1.... due to confusion over the VAT', said Deepak Sinha...atients in a difficult situation as medicines for ...
...oward and the Federal Government has put together ...lp those suffering from mental illness//, as well ...ed this week a $1.8 billion boost for mental heal... consultations with psychologists wining plenty of...
...nd Family Welfare Minister of Bangladesh, Dr Khand...ector is asymmetrical// to the present population ...ief guest at the Osmani Memorial Auditorium on the...id that about 38,206 physicians were working in th...
Other Medicine News:Health News:Alcoholism Linked To Higher Death Rates Among Older Men 2Health News:Medicare Benefits For Patients seeking Psychiatric Help 2(Date:9/5/2008)...t. 5 /- SARcode,Corporation...1 inhibitors,to treat inflammatory diseases, and S...announced SARcode,s initiation of a Phase 1 clinic...te for T-cell mediated ophthalmic,diseases. Sunesi...viding,SARcode with an exclusive license to Sunesi...
(Date:9/4/2008)...wswire-FirstCall/ -- BioForm Medical,Inc. (Nasdaq...l study of,Polidocanol, conducted in Germany by Bi...R & Co. GmbH (Kreussler), successfully met the stu...as part of a New Drug Application,(NDA) process., ...ficacy and safety of,Aethoxysklerol compared to So...
(Date:9/4/2008)...omen at More Than 100 Sites in the U.S., ANN ARBO...ticals, a,privately-held biopharmaceutical company...ompounds to treat endocrine, metabolic and,cardiov...tiated a second,Phase 3 clinical trial of Ophena(T...ee oral therapy in development for the treatment o...
(Date:9/4/2008)...dule with Two Abstracts Accepted for Presentat...008, BRIDGEWATER, N.J., Sept. 4 /- A...eutical company focused on the treatment of,cardio...e appointment of,Peter L. Garrambone, Jr. to the C...career includes more than 50 pharmaceutical,transa...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Inverted DNA turns quiet developmental gene into a potent driver of t cell lymphoma 12917 1Inverted DNA turns quiet developmental gene into a potent driver of t cell lymphoma 12917 2U of Minn researchers find primary alcohol prevention programs are needed for tweens 12914 1U of Minn researchers find primary alcohol prevention programs are needed for tweens 12914 2APIC Selected as Faculty in Blue Shield of California Foundation Initiative to Fight Healthcare Associated Infections 12910 1VA Has Added 20 New Vet Centers 12908 1VA Has Added 20 New Vet Centers 12908 27 mm blade, angled right. Flat handle.
1 mm diameter. Angled 33 degrees. Round handle.
3.5 mm blade. Round handle. Designated most popular model or size.
7 mm curved blade. Round handle.
Medicine Products: